These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17264348)

  • 21. Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials.
    Bria E; Gralla RJ; Raftopoulos H; Cuppone F; Milella M; Sperduti I; Carlini P; Terzoli E; Cognetti F; Giannarelli D
    Lung Cancer; 2009 Jan; 63(1):50-7. PubMed ID: 18565615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Letter to the editor.
    Burdett S; Stewart L; Stephens R; Auperin A; Pignon JP; Chevalier TL; Pechoux CL
    Lung Cancer; 2005 Apr; 48(1):149-50. PubMed ID: 15777984
    [No Abstract]   [Full Text] [Related]  

  • 23. Postoperative radiation therapy for non-small cell lung cancer.
    Decker RH; Wilson LD
    Semin Thorac Cardiovasc Surg; 2008; 20(3):184-7. PubMed ID: 19038726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scalpels, beams, drugs, and dreams: challenges of stage IIIA-N2 non-small-cell lung cancer.
    Johnson DH; Rusch VW; Turrisi AT
    J Natl Cancer Inst; 2007 Mar; 99(6):415-8. PubMed ID: 17374824
    [No Abstract]   [Full Text] [Related]  

  • 25. Estimating the magnitude and field-size dependence of radiotherapy-induced mortality and tumor control after postoperative radiotherapy for non-small-cell lung cancer: calculations from clinical trials.
    Miles EF; Kelsey CR; Kirkpatrick JP; Marks LB
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1047-52. PubMed ID: 17507176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What should the optimal timing be for amifostine administration relative to radiation and chemotherapy?
    Komaki R
    J Clin Oncol; 2005 Oct; 23(28):7232-3; author reply 7233-5. PubMed ID: 16192612
    [No Abstract]   [Full Text] [Related]  

  • 27. Postoperative radiotherapy in non-small-cell lung cancer.
    Machtay M
    Lancet; 1998 Oct; 352(9137):1384-5; author reply 1385-6. PubMed ID: 9802293
    [No Abstract]   [Full Text] [Related]  

  • 28. What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?
    Van Meerbeeck JP; De Pauw R; Tournoy K
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):199-206. PubMed ID: 18279061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
    Rusu P; Ciuleanu TE; Cernea D; Pelau D; Gaal V; Cebotaru C; Guttman T; Todor N; Ghilezan N
    J BUON; 2007; 12(1):33-9. PubMed ID: 17436399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Foreword; challenging the 'one-size-fits-all' approach of chemotherapy and radiotherapy for patients with non-small cell lung cancer.
    Kris MG
    Lung Cancer; 2008 Jun; 60 Suppl 2():S1-2. PubMed ID: 18513578
    [No Abstract]   [Full Text] [Related]  

  • 31. Overestimating the influence of the 1999 WHO classification of lung tumors on survival in bronchioloalveloar carcinoma.
    Tsurutani J; Ballas MS; Dennis PA
    J Clin Oncol; 2006 Apr; 24(12):1963; author reply 1963-4. PubMed ID: 16622278
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of radiotherapy in lung cancer: where is the evidence?
    Jassem J
    Radiother Oncol; 2007 May; 83(2):203-13. PubMed ID: 17482301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of radiotherapy and chemotherapy in locally advanced NSCLC.
    Kepka L; Sprawka A; Casas F; Abdel-Wahab S; Agarwal JP; Jeremic B
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1389-403. PubMed ID: 19827998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.
    Jiang J; Liang X; Zhou X; Huang R; Chu Z
    Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
    Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
    Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postoperative radiotherapy in completely resected, early-stage, non-small-cell lung cancer: reflections and future directions.
    Granone P; Keller S; Trodella L; Cesario A; Margaritora S; Porziella V; Valente S; Corbo GM; d'Angelillo R
    Lancet Oncol; 2002 Oct; 3(10):589-90; discussion 590-1. PubMed ID: 12372718
    [No Abstract]   [Full Text] [Related]  

  • 37. [Lung cancer].
    Tsuboi M; Kato H
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1538-42. PubMed ID: 17940368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re-evaluating duration of therapy in advanced non-small-cell lung cancer: is it really duration or is it more about timing and exposure?
    Socinski MA
    J Clin Oncol; 2009 Jul; 27(20):3268-70. PubMed ID: 19470913
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparison of survival and disease-specific survival in surgically resected, lymph node-positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer: implications for adjuvant therapy.
    Varlotto JM; Flickinger JC; Recht A; Nikolov MC; DeCamp MM
    Cancer; 2008 Apr; 112(7):1547-54. PubMed ID: 18260087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant chemotherapy in the treatment of nonsmall-cell lung cancer.
    De Pauw R; van Meerbeeck JP
    Curr Opin Oncol; 2007 Mar; 19(2):92-7. PubMed ID: 17272979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.